Global IVT mRNA Synthesis Service Supply, Demand and Key Producers, 2026-2032
The global IVT mRNA Synthesis Service market size is expected to reach $ 1768 million by 2032, rising at a market growth of 7.5% CAGR during the forecast period (2026-2032).
IVT mRNA synthesis services use plasmid DNA or linear DNA as the transcription template and RNA polymerases such as T7 or SP6 to produce customized mRNA through in vitro transcription. Depending on project requirements, the service may include 5? capping, 3? poly(A) tail construction, nucleotide modification, purification, bioburden control, and quality testing, delivering mRNA drug substance for research, preclinical, clinical, or commercial applications. Major upstream inputs include DNA templates, natural and modified NTPs, RNA polymerases, cap analogs or capping enzymes, poly(A) polymerase, DNase, buffers, chromatography resins, ultrafiltration membranes, and single-use consumables. Major downstream customers include pharmaceutical and biotechnology companies, academic and research institutions, CROs, CDMOs, and selected diagnostic developers. The industry's overall gross profit margin is approximately 42%?60%.
The global IVT mRNA synthesis service market has shifted from pandemic-driven, large-scale vaccine capacity expansion toward a normalized market supported by discovery research, preclinical development, personalized therapies, and diversified clinical pipelines. Research-grade orders are numerous but generally have low individual values, while clinical and GMP projects are less frequent but contribute substantially higher project revenue. Customers increasingly evaluate suppliers based not only on transcription yield, but also on RNA integrity, capping efficiency, poly(A) tail consistency, residual DNA, double-stranded RNA impurities, endotoxin control, and the transferability of analytical methods. Providers capable of supporting projects continuously from screening through GMP manufacturing are better positioned to retain customers.
Technology development is moving toward higher expression, lower immunogenicity, and more consistent manufacturing processes. Modified nucleotides, co-transcriptional capping, controlled poly(A) tail engineering, low-dsRNA transcription systems, and high-resolution purification are becoming major competitive factors. The development of self-amplifying RNA is also requiring providers to improve long RNA manufacturing and structural control. High-throughput construct screening, codon and UTR optimization, digital sequence design, and automated small-scale production are shortening candidate selection cycles. Linear DNA and cell-free template technologies are also emerging as alternatives to conventional plasmid templates, potentially reducing template preparation time and improving supply chain flexibility.
Demand is primarily driven by the expansion of mRNA applications and the increasing use of outsourced development and manufacturing. Beyond infectious disease vaccines, oncology vaccines, protein replacement, in vivo gene editing, immune-cell engineering, and rare disease therapies are generating new projects. Small and medium-sized biotechnology companies often lack dedicated RNA manufacturing facilities, analytical methods, and GMP quality systems, making outsourcing an attractive option. Large pharmaceutical companies also use external suppliers when internal capacity is constrained, a second source is required, or multiple constructs must be screened. Suppliers that maintain continuity in raw materials, processes, and analytical methods across development stages have a stronger competitive position.
The industry continues to face capacity mismatch, low pipeline conversion rates, and evolving regulatory expectations. Some large-scale vaccine capacity built during the pandemic is not directly suited to small-batch, personalized, or multi-product programs, while early-stage projects may require long development periods before reaching clinical or commercial manufacturing. Intellectual property associated with critical enzymes, modified nucleotides, capping technologies, and delivery lipids can increase project cost and licensing complexity. RNA stability, frozen storage, and cross-border transportation also complicate delivery. Price competition remains significant in the research-grade segment, while in-house manufacturing by major pharmaceutical companies limits part of the outsourcing opportunity. Future market development will favor platform providers with flexible scales, differentiated processes, and mature quality systems.
This report studies the global IVT mRNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for IVT mRNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of IVT mRNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global IVT mRNA Synthesis Service total market, 2021-2032, (USD Million)
Global IVT mRNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: IVT mRNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global IVT mRNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global IVT mRNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global IVT mRNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global IVT mRNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, GenScript, Azenta, Eurofins Scientific, Lonza, Catalent, Thermo Fisher Scientific, Merck KGaA, AGC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world IVT mRNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global IVT mRNA Synthesis Service Market, By Region:
1. How big is the global IVT mRNA Synthesis Service market?
2. What is the demand of the global IVT mRNA Synthesis Service market?
3. What is the year over year growth of the global IVT mRNA Synthesis Service market?
4. What is the total value of the global IVT mRNA Synthesis Service market?
5. Who are the Major Players in the global IVT mRNA Synthesis Service market?
6. What are the growth factors driving the market demand?
IVT mRNA synthesis services use plasmid DNA or linear DNA as the transcription template and RNA polymerases such as T7 or SP6 to produce customized mRNA through in vitro transcription. Depending on project requirements, the service may include 5? capping, 3? poly(A) tail construction, nucleotide modification, purification, bioburden control, and quality testing, delivering mRNA drug substance for research, preclinical, clinical, or commercial applications. Major upstream inputs include DNA templates, natural and modified NTPs, RNA polymerases, cap analogs or capping enzymes, poly(A) polymerase, DNase, buffers, chromatography resins, ultrafiltration membranes, and single-use consumables. Major downstream customers include pharmaceutical and biotechnology companies, academic and research institutions, CROs, CDMOs, and selected diagnostic developers. The industry's overall gross profit margin is approximately 42%?60%.
The global IVT mRNA synthesis service market has shifted from pandemic-driven, large-scale vaccine capacity expansion toward a normalized market supported by discovery research, preclinical development, personalized therapies, and diversified clinical pipelines. Research-grade orders are numerous but generally have low individual values, while clinical and GMP projects are less frequent but contribute substantially higher project revenue. Customers increasingly evaluate suppliers based not only on transcription yield, but also on RNA integrity, capping efficiency, poly(A) tail consistency, residual DNA, double-stranded RNA impurities, endotoxin control, and the transferability of analytical methods. Providers capable of supporting projects continuously from screening through GMP manufacturing are better positioned to retain customers.
Technology development is moving toward higher expression, lower immunogenicity, and more consistent manufacturing processes. Modified nucleotides, co-transcriptional capping, controlled poly(A) tail engineering, low-dsRNA transcription systems, and high-resolution purification are becoming major competitive factors. The development of self-amplifying RNA is also requiring providers to improve long RNA manufacturing and structural control. High-throughput construct screening, codon and UTR optimization, digital sequence design, and automated small-scale production are shortening candidate selection cycles. Linear DNA and cell-free template technologies are also emerging as alternatives to conventional plasmid templates, potentially reducing template preparation time and improving supply chain flexibility.
Demand is primarily driven by the expansion of mRNA applications and the increasing use of outsourced development and manufacturing. Beyond infectious disease vaccines, oncology vaccines, protein replacement, in vivo gene editing, immune-cell engineering, and rare disease therapies are generating new projects. Small and medium-sized biotechnology companies often lack dedicated RNA manufacturing facilities, analytical methods, and GMP quality systems, making outsourcing an attractive option. Large pharmaceutical companies also use external suppliers when internal capacity is constrained, a second source is required, or multiple constructs must be screened. Suppliers that maintain continuity in raw materials, processes, and analytical methods across development stages have a stronger competitive position.
The industry continues to face capacity mismatch, low pipeline conversion rates, and evolving regulatory expectations. Some large-scale vaccine capacity built during the pandemic is not directly suited to small-batch, personalized, or multi-product programs, while early-stage projects may require long development periods before reaching clinical or commercial manufacturing. Intellectual property associated with critical enzymes, modified nucleotides, capping technologies, and delivery lipids can increase project cost and licensing complexity. RNA stability, frozen storage, and cross-border transportation also complicate delivery. Price competition remains significant in the research-grade segment, while in-house manufacturing by major pharmaceutical companies limits part of the outsourcing opportunity. Future market development will favor platform providers with flexible scales, differentiated processes, and mature quality systems.
This report studies the global IVT mRNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for IVT mRNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of IVT mRNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global IVT mRNA Synthesis Service total market, 2021-2032, (USD Million)
Global IVT mRNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: IVT mRNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global IVT mRNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global IVT mRNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global IVT mRNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global IVT mRNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, GenScript, Azenta, Eurofins Scientific, Lonza, Catalent, Thermo Fisher Scientific, Merck KGaA, AGC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world IVT mRNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global IVT mRNA Synthesis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Research Grade
- Preclinical Grade
- GMP Grade
- Other
- Micro Scale (?1 mg)
- Small Scale (>1?100 mg)
- Pilot Scale (>100 mg?10 g)
- Manufacturing Scale (>10 g)
- Conventional mRNA
- Self-Amplifying RNA
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other
- Maravai LifeSciences
- Danaher
- GenScript
- Azenta
- Eurofins Scientific
- Lonza
- Catalent
- Thermo Fisher Scientific
- Merck KGaA
- AGC
- Samsung Biologics
- Recipharm
- Curia
- VectorBuilder
- Biomay
- Ricoh
- ARCALIS
- Bioneer
1. How big is the global IVT mRNA Synthesis Service market?
2. What is the demand of the global IVT mRNA Synthesis Service market?
3. What is the year over year growth of the global IVT mRNA Synthesis Service market?
4. What is the total value of the global IVT mRNA Synthesis Service market?
5. Who are the Major Players in the global IVT mRNA Synthesis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 IVT mRNA Synthesis Service Introduction
1.2 World IVT mRNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World IVT mRNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World IVT mRNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 IVT mRNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.2 World IVT mRNA Synthesis Service Consumption Value by Region
2.2.1 World IVT mRNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World IVT mRNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.4 China IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.9 India IVT mRNA Synthesis Service Consumption Value (2021-2032)
3 WORLD IVT MRNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World IVT mRNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global IVT mRNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for IVT mRNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for IVT mRNA Synthesis Service in 2025
3.3 IVT mRNA Synthesis Service Company Evaluation Quadrant
3.4 IVT mRNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 IVT mRNA Synthesis Service Market: Region Footprint
3.4.2 IVT mRNA Synthesis Service Market: Company Product Type Footprint
3.4.3 IVT mRNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: IVT mRNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: IVT mRNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: IVT mRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: IVT mRNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: IVT mRNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: IVT mRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based IVT mRNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based IVT mRNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies IVT mRNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based IVT mRNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based IVT mRNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies IVT mRNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World IVT mRNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Research Grade
5.2.2 Preclinical Grade
5.2.3 GMP Grade
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World IVT mRNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World IVT mRNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BATCH SCALE
6.1 World IVT mRNA Synthesis Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Batch Scale
6.2.1 Micro Scale (?1 mg)
6.2.2 Small Scale (>1?100 mg)
6.2.3 Pilot Scale (>100 mg?10 g)
6.2.4 Manufacturing Scale (>10 g)
6.3 Market Segment by Batch Scale
6.3.1 World IVT mRNA Synthesis Service Market Size by Batch Scale (2021-2026)
6.3.2 World IVT mRNA Synthesis Service Market Size by Batch Scale (2027-2032)
6.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale (2027-2032)
7 MARKET ANALYSIS BY RNA FORMAT
7.1 World IVT mRNA Synthesis Service Market Size Overview by RNA Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by RNA Format
7.2.1 Conventional mRNA
7.2.2 Self-Amplifying RNA
7.3 Market Segment by RNA Format
7.3.1 World IVT mRNA Synthesis Service Market Size by RNA Format (2021-2026)
7.3.2 World IVT mRNA Synthesis Service Market Size by RNA Format (2027-2032)
7.3.3 World IVT mRNA Synthesis Service Market Size Market Share by RNA Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World IVT mRNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World IVT mRNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World IVT mRNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences IVT mRNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher IVT mRNA Synthesis Service Product and Services
9.2.4 Danaher IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 GenScript
9.3.1 GenScript Details
9.3.2 GenScript Major Business
9.3.3 GenScript IVT mRNA Synthesis Service Product and Services
9.3.4 GenScript IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 GenScript Recent Developments/Updates
9.3.6 GenScript Competitive Strengths & Weaknesses
9.4 Azenta
9.4.1 Azenta Details
9.4.2 Azenta Major Business
9.4.3 Azenta IVT mRNA Synthesis Service Product and Services
9.4.4 Azenta IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Azenta Recent Developments/Updates
9.4.6 Azenta Competitive Strengths & Weaknesses
9.5 Eurofins Scientific
9.5.1 Eurofins Scientific Details
9.5.2 Eurofins Scientific Major Business
9.5.3 Eurofins Scientific IVT mRNA Synthesis Service Product and Services
9.5.4 Eurofins Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Eurofins Scientific Recent Developments/Updates
9.5.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.6 Lonza
9.6.1 Lonza Details
9.6.2 Lonza Major Business
9.6.3 Lonza IVT mRNA Synthesis Service Product and Services
9.6.4 Lonza IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Lonza Recent Developments/Updates
9.6.6 Lonza Competitive Strengths & Weaknesses
9.7 Catalent
9.7.1 Catalent Details
9.7.2 Catalent Major Business
9.7.3 Catalent IVT mRNA Synthesis Service Product and Services
9.7.4 Catalent IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Recent Developments/Updates
9.7.6 Catalent Competitive Strengths & Weaknesses
9.8 Thermo Fisher Scientific
9.8.1 Thermo Fisher Scientific Details
9.8.2 Thermo Fisher Scientific Major Business
9.8.3 Thermo Fisher Scientific IVT mRNA Synthesis Service Product and Services
9.8.4 Thermo Fisher Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Thermo Fisher Scientific Recent Developments/Updates
9.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.9 Merck KGaA
9.9.1 Merck KGaA Details
9.9.2 Merck KGaA Major Business
9.9.3 Merck KGaA IVT mRNA Synthesis Service Product and Services
9.9.4 Merck KGaA IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Merck KGaA Recent Developments/Updates
9.9.6 Merck KGaA Competitive Strengths & Weaknesses
9.10 AGC
9.10.1 AGC Details
9.10.2 AGC Major Business
9.10.3 AGC IVT mRNA Synthesis Service Product and Services
9.10.4 AGC IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Recent Developments/Updates
9.10.6 AGC Competitive Strengths & Weaknesses
9.11 Samsung Biologics
9.11.1 Samsung Biologics Details
9.11.2 Samsung Biologics Major Business
9.11.3 Samsung Biologics IVT mRNA Synthesis Service Product and Services
9.11.4 Samsung Biologics IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Samsung Biologics Recent Developments/Updates
9.11.6 Samsung Biologics Competitive Strengths & Weaknesses
9.12 Recipharm
9.12.1 Recipharm Details
9.12.2 Recipharm Major Business
9.12.3 Recipharm IVT mRNA Synthesis Service Product and Services
9.12.4 Recipharm IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Recipharm Recent Developments/Updates
9.12.6 Recipharm Competitive Strengths & Weaknesses
9.13 Curia
9.13.1 Curia Details
9.13.2 Curia Major Business
9.13.3 Curia IVT mRNA Synthesis Service Product and Services
9.13.4 Curia IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Curia Recent Developments/Updates
9.13.6 Curia Competitive Strengths & Weaknesses
9.14 VectorBuilder
9.14.1 VectorBuilder Details
9.14.2 VectorBuilder Major Business
9.14.3 VectorBuilder IVT mRNA Synthesis Service Product and Services
9.14.4 VectorBuilder IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 VectorBuilder Recent Developments/Updates
9.14.6 VectorBuilder Competitive Strengths & Weaknesses
9.15 Biomay
9.15.1 Biomay Details
9.15.2 Biomay Major Business
9.15.3 Biomay IVT mRNA Synthesis Service Product and Services
9.15.4 Biomay IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biomay Recent Developments/Updates
9.15.6 Biomay Competitive Strengths & Weaknesses
9.16 Ricoh
9.16.1 Ricoh Details
9.16.2 Ricoh Major Business
9.16.3 Ricoh IVT mRNA Synthesis Service Product and Services
9.16.4 Ricoh IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Ricoh Recent Developments/Updates
9.16.6 Ricoh Competitive Strengths & Weaknesses
9.17 ARCALIS
9.17.1 ARCALIS Details
9.17.2 ARCALIS Major Business
9.17.3 ARCALIS IVT mRNA Synthesis Service Product and Services
9.17.4 ARCALIS IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 ARCALIS Recent Developments/Updates
9.17.6 ARCALIS Competitive Strengths & Weaknesses
9.18 Bioneer
9.18.1 Bioneer Details
9.18.2 Bioneer Major Business
9.18.3 Bioneer IVT mRNA Synthesis Service Product and Services
9.18.4 Bioneer IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Bioneer Recent Developments/Updates
9.18.6 Bioneer Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 IVT mRNA Synthesis Service Industry Chain
10.2 IVT mRNA Synthesis Service Upstream Analysis
10.3 IVT mRNA Synthesis Service Midstream Analysis
10.4 IVT mRNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 IVT mRNA Synthesis Service Introduction
1.2 World IVT mRNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World IVT mRNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World IVT mRNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company IVT mRNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 IVT mRNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.2 World IVT mRNA Synthesis Service Consumption Value by Region
2.2.1 World IVT mRNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World IVT mRNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.4 China IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN IVT mRNA Synthesis Service Consumption Value (2021-2032)
2.9 India IVT mRNA Synthesis Service Consumption Value (2021-2032)
3 WORLD IVT MRNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World IVT mRNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global IVT mRNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for IVT mRNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for IVT mRNA Synthesis Service in 2025
3.3 IVT mRNA Synthesis Service Company Evaluation Quadrant
3.4 IVT mRNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 IVT mRNA Synthesis Service Market: Region Footprint
3.4.2 IVT mRNA Synthesis Service Market: Company Product Type Footprint
3.4.3 IVT mRNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: IVT mRNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: IVT mRNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: IVT mRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: IVT mRNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: IVT mRNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: IVT mRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based IVT mRNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based IVT mRNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies IVT mRNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based IVT mRNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based IVT mRNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies IVT mRNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World IVT mRNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Research Grade
5.2.2 Preclinical Grade
5.2.3 GMP Grade
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World IVT mRNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World IVT mRNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BATCH SCALE
6.1 World IVT mRNA Synthesis Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Batch Scale
6.2.1 Micro Scale (?1 mg)
6.2.2 Small Scale (>1?100 mg)
6.2.3 Pilot Scale (>100 mg?10 g)
6.2.4 Manufacturing Scale (>10 g)
6.3 Market Segment by Batch Scale
6.3.1 World IVT mRNA Synthesis Service Market Size by Batch Scale (2021-2026)
6.3.2 World IVT mRNA Synthesis Service Market Size by Batch Scale (2027-2032)
6.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale (2027-2032)
7 MARKET ANALYSIS BY RNA FORMAT
7.1 World IVT mRNA Synthesis Service Market Size Overview by RNA Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by RNA Format
7.2.1 Conventional mRNA
7.2.2 Self-Amplifying RNA
7.3 Market Segment by RNA Format
7.3.1 World IVT mRNA Synthesis Service Market Size by RNA Format (2021-2026)
7.3.2 World IVT mRNA Synthesis Service Market Size by RNA Format (2027-2032)
7.3.3 World IVT mRNA Synthesis Service Market Size Market Share by RNA Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World IVT mRNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World IVT mRNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World IVT mRNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World IVT mRNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences IVT mRNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher IVT mRNA Synthesis Service Product and Services
9.2.4 Danaher IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 GenScript
9.3.1 GenScript Details
9.3.2 GenScript Major Business
9.3.3 GenScript IVT mRNA Synthesis Service Product and Services
9.3.4 GenScript IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 GenScript Recent Developments/Updates
9.3.6 GenScript Competitive Strengths & Weaknesses
9.4 Azenta
9.4.1 Azenta Details
9.4.2 Azenta Major Business
9.4.3 Azenta IVT mRNA Synthesis Service Product and Services
9.4.4 Azenta IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Azenta Recent Developments/Updates
9.4.6 Azenta Competitive Strengths & Weaknesses
9.5 Eurofins Scientific
9.5.1 Eurofins Scientific Details
9.5.2 Eurofins Scientific Major Business
9.5.3 Eurofins Scientific IVT mRNA Synthesis Service Product and Services
9.5.4 Eurofins Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Eurofins Scientific Recent Developments/Updates
9.5.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.6 Lonza
9.6.1 Lonza Details
9.6.2 Lonza Major Business
9.6.3 Lonza IVT mRNA Synthesis Service Product and Services
9.6.4 Lonza IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Lonza Recent Developments/Updates
9.6.6 Lonza Competitive Strengths & Weaknesses
9.7 Catalent
9.7.1 Catalent Details
9.7.2 Catalent Major Business
9.7.3 Catalent IVT mRNA Synthesis Service Product and Services
9.7.4 Catalent IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Recent Developments/Updates
9.7.6 Catalent Competitive Strengths & Weaknesses
9.8 Thermo Fisher Scientific
9.8.1 Thermo Fisher Scientific Details
9.8.2 Thermo Fisher Scientific Major Business
9.8.3 Thermo Fisher Scientific IVT mRNA Synthesis Service Product and Services
9.8.4 Thermo Fisher Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Thermo Fisher Scientific Recent Developments/Updates
9.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.9 Merck KGaA
9.9.1 Merck KGaA Details
9.9.2 Merck KGaA Major Business
9.9.3 Merck KGaA IVT mRNA Synthesis Service Product and Services
9.9.4 Merck KGaA IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Merck KGaA Recent Developments/Updates
9.9.6 Merck KGaA Competitive Strengths & Weaknesses
9.10 AGC
9.10.1 AGC Details
9.10.2 AGC Major Business
9.10.3 AGC IVT mRNA Synthesis Service Product and Services
9.10.4 AGC IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Recent Developments/Updates
9.10.6 AGC Competitive Strengths & Weaknesses
9.11 Samsung Biologics
9.11.1 Samsung Biologics Details
9.11.2 Samsung Biologics Major Business
9.11.3 Samsung Biologics IVT mRNA Synthesis Service Product and Services
9.11.4 Samsung Biologics IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Samsung Biologics Recent Developments/Updates
9.11.6 Samsung Biologics Competitive Strengths & Weaknesses
9.12 Recipharm
9.12.1 Recipharm Details
9.12.2 Recipharm Major Business
9.12.3 Recipharm IVT mRNA Synthesis Service Product and Services
9.12.4 Recipharm IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Recipharm Recent Developments/Updates
9.12.6 Recipharm Competitive Strengths & Weaknesses
9.13 Curia
9.13.1 Curia Details
9.13.2 Curia Major Business
9.13.3 Curia IVT mRNA Synthesis Service Product and Services
9.13.4 Curia IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Curia Recent Developments/Updates
9.13.6 Curia Competitive Strengths & Weaknesses
9.14 VectorBuilder
9.14.1 VectorBuilder Details
9.14.2 VectorBuilder Major Business
9.14.3 VectorBuilder IVT mRNA Synthesis Service Product and Services
9.14.4 VectorBuilder IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 VectorBuilder Recent Developments/Updates
9.14.6 VectorBuilder Competitive Strengths & Weaknesses
9.15 Biomay
9.15.1 Biomay Details
9.15.2 Biomay Major Business
9.15.3 Biomay IVT mRNA Synthesis Service Product and Services
9.15.4 Biomay IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biomay Recent Developments/Updates
9.15.6 Biomay Competitive Strengths & Weaknesses
9.16 Ricoh
9.16.1 Ricoh Details
9.16.2 Ricoh Major Business
9.16.3 Ricoh IVT mRNA Synthesis Service Product and Services
9.16.4 Ricoh IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Ricoh Recent Developments/Updates
9.16.6 Ricoh Competitive Strengths & Weaknesses
9.17 ARCALIS
9.17.1 ARCALIS Details
9.17.2 ARCALIS Major Business
9.17.3 ARCALIS IVT mRNA Synthesis Service Product and Services
9.17.4 ARCALIS IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 ARCALIS Recent Developments/Updates
9.17.6 ARCALIS Competitive Strengths & Weaknesses
9.18 Bioneer
9.18.1 Bioneer Details
9.18.2 Bioneer Major Business
9.18.3 Bioneer IVT mRNA Synthesis Service Product and Services
9.18.4 Bioneer IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Bioneer Recent Developments/Updates
9.18.6 Bioneer Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 IVT mRNA Synthesis Service Industry Chain
10.2 IVT mRNA Synthesis Service Upstream Analysis
10.3 IVT mRNA Synthesis Service Midstream Analysis
10.4 IVT mRNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World IVT mRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World IVT mRNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World IVT mRNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World IVT mRNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World IVT mRNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World IVT mRNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World IVT mRNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World IVT mRNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World IVT mRNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key IVT mRNA Synthesis Service Players in 2025
Table 12. World IVT mRNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global IVT mRNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key IVT mRNA Synthesis Service Players
Table 15. IVT mRNA Synthesis Service Market: Company Product Type Footprint
Table 16. IVT mRNA Synthesis Service Market: Company Product Application Footprint
Table 17. IVT mRNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China IVT mRNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China IVT mRNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based IVT mRNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies IVT mRNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World IVT mRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World IVT mRNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World IVT mRNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World IVT mRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 33. World IVT mRNA Synthesis Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 34. World IVT mRNA Synthesis Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 35. World IVT mRNA Synthesis Service Market Size by RNA Format, (USD Million), 2021 & 2025 & 2032
Table 36. World IVT mRNA Synthesis Service Market Size Value by RNA Format (2021-2026) & (USD Million)
Table 37. World IVT mRNA Synthesis Service Market Size by RNA Format (2027-2032) & (USD Million)
Table 38. World IVT mRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World IVT mRNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World IVT mRNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences IVT mRNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher IVT mRNA Synthesis Service Product and Services
Table 50. Danaher IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. GenScript Basic Information, Manufacturing Base and Competitors
Table 54. GenScript Major Business
Table 55. GenScript IVT mRNA Synthesis Service Product and Services
Table 56. GenScript IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GenScript Recent Developments/Updates
Table 58. GenScript Competitive Strengths & Weaknesses
Table 59. Azenta Basic Information, Manufacturing Base and Competitors
Table 60. Azenta Major Business
Table 61. Azenta IVT mRNA Synthesis Service Product and Services
Table 62. Azenta IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Azenta Recent Developments/Updates
Table 64. Azenta Competitive Strengths & Weaknesses
Table 65. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 66. Eurofins Scientific Major Business
Table 67. Eurofins Scientific IVT mRNA Synthesis Service Product and Services
Table 68. Eurofins Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Eurofins Scientific Recent Developments/Updates
Table 70. Eurofins Scientific Competitive Strengths & Weaknesses
Table 71. Lonza Basic Information, Manufacturing Base and Competitors
Table 72. Lonza Major Business
Table 73. Lonza IVT mRNA Synthesis Service Product and Services
Table 74. Lonza IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Lonza Recent Developments/Updates
Table 76. Lonza Competitive Strengths & Weaknesses
Table 77. Catalent Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Major Business
Table 79. Catalent IVT mRNA Synthesis Service Product and Services
Table 80. Catalent IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Recent Developments/Updates
Table 82. Catalent Competitive Strengths & Weaknesses
Table 83. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 84. Thermo Fisher Scientific Major Business
Table 85. Thermo Fisher Scientific IVT mRNA Synthesis Service Product and Services
Table 86. Thermo Fisher Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Thermo Fisher Scientific Recent Developments/Updates
Table 88. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 89. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 90. Merck KGaA Major Business
Table 91. Merck KGaA IVT mRNA Synthesis Service Product and Services
Table 92. Merck KGaA IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Merck KGaA Recent Developments/Updates
Table 94. Merck KGaA Competitive Strengths & Weaknesses
Table 95. AGC Basic Information, Manufacturing Base and Competitors
Table 96. AGC Major Business
Table 97. AGC IVT mRNA Synthesis Service Product and Services
Table 98. AGC IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Recent Developments/Updates
Table 100. AGC Competitive Strengths & Weaknesses
Table 101. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 102. Samsung Biologics Major Business
Table 103. Samsung Biologics IVT mRNA Synthesis Service Product and Services
Table 104. Samsung Biologics IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Samsung Biologics Recent Developments/Updates
Table 106. Samsung Biologics Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Manufacturing Base and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm IVT mRNA Synthesis Service Product and Services
Table 110. Recipharm IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. Curia Basic Information, Manufacturing Base and Competitors
Table 114. Curia Major Business
Table 115. Curia IVT mRNA Synthesis Service Product and Services
Table 116. Curia IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Curia Recent Developments/Updates
Table 118. Curia Competitive Strengths & Weaknesses
Table 119. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 120. VectorBuilder Major Business
Table 121. VectorBuilder IVT mRNA Synthesis Service Product and Services
Table 122. VectorBuilder IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. VectorBuilder Recent Developments/Updates
Table 124. VectorBuilder Competitive Strengths & Weaknesses
Table 125. Biomay Basic Information, Manufacturing Base and Competitors
Table 126. Biomay Major Business
Table 127. Biomay IVT mRNA Synthesis Service Product and Services
Table 128. Biomay IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biomay Recent Developments/Updates
Table 130. Biomay Competitive Strengths & Weaknesses
Table 131. Ricoh Basic Information, Manufacturing Base and Competitors
Table 132. Ricoh Major Business
Table 133. Ricoh IVT mRNA Synthesis Service Product and Services
Table 134. Ricoh IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Ricoh Recent Developments/Updates
Table 136. Ricoh Competitive Strengths & Weaknesses
Table 137. ARCALIS Basic Information, Manufacturing Base and Competitors
Table 138. ARCALIS Major Business
Table 139. ARCALIS IVT mRNA Synthesis Service Product and Services
Table 140. ARCALIS IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. ARCALIS Recent Developments/Updates
Table 142. ARCALIS Competitive Strengths & Weaknesses
Table 143. Bioneer Basic Information, Manufacturing Base and Competitors
Table 144. Bioneer Major Business
Table 145. Bioneer IVT mRNA Synthesis Service Product and Services
Table 146. Bioneer IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Bioneer Recent Developments/Updates
Table 148. Bioneer Competitive Strengths & Weaknesses
Table 149. Global Key Players of IVT mRNA Synthesis Service Upstream (Raw Materials)
Table 150. Global IVT mRNA Synthesis Service Typical Customers
Table 1. World IVT mRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World IVT mRNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World IVT mRNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World IVT mRNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World IVT mRNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World IVT mRNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World IVT mRNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World IVT mRNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World IVT mRNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key IVT mRNA Synthesis Service Players in 2025
Table 12. World IVT mRNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global IVT mRNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key IVT mRNA Synthesis Service Players
Table 15. IVT mRNA Synthesis Service Market: Company Product Type Footprint
Table 16. IVT mRNA Synthesis Service Market: Company Product Application Footprint
Table 17. IVT mRNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China IVT mRNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China IVT mRNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based IVT mRNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies IVT mRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based IVT mRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies IVT mRNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies IVT mRNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World IVT mRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World IVT mRNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World IVT mRNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World IVT mRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 33. World IVT mRNA Synthesis Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 34. World IVT mRNA Synthesis Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 35. World IVT mRNA Synthesis Service Market Size by RNA Format, (USD Million), 2021 & 2025 & 2032
Table 36. World IVT mRNA Synthesis Service Market Size Value by RNA Format (2021-2026) & (USD Million)
Table 37. World IVT mRNA Synthesis Service Market Size by RNA Format (2027-2032) & (USD Million)
Table 38. World IVT mRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World IVT mRNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World IVT mRNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences IVT mRNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher IVT mRNA Synthesis Service Product and Services
Table 50. Danaher IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. GenScript Basic Information, Manufacturing Base and Competitors
Table 54. GenScript Major Business
Table 55. GenScript IVT mRNA Synthesis Service Product and Services
Table 56. GenScript IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GenScript Recent Developments/Updates
Table 58. GenScript Competitive Strengths & Weaknesses
Table 59. Azenta Basic Information, Manufacturing Base and Competitors
Table 60. Azenta Major Business
Table 61. Azenta IVT mRNA Synthesis Service Product and Services
Table 62. Azenta IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Azenta Recent Developments/Updates
Table 64. Azenta Competitive Strengths & Weaknesses
Table 65. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 66. Eurofins Scientific Major Business
Table 67. Eurofins Scientific IVT mRNA Synthesis Service Product and Services
Table 68. Eurofins Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Eurofins Scientific Recent Developments/Updates
Table 70. Eurofins Scientific Competitive Strengths & Weaknesses
Table 71. Lonza Basic Information, Manufacturing Base and Competitors
Table 72. Lonza Major Business
Table 73. Lonza IVT mRNA Synthesis Service Product and Services
Table 74. Lonza IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Lonza Recent Developments/Updates
Table 76. Lonza Competitive Strengths & Weaknesses
Table 77. Catalent Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Major Business
Table 79. Catalent IVT mRNA Synthesis Service Product and Services
Table 80. Catalent IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Recent Developments/Updates
Table 82. Catalent Competitive Strengths & Weaknesses
Table 83. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 84. Thermo Fisher Scientific Major Business
Table 85. Thermo Fisher Scientific IVT mRNA Synthesis Service Product and Services
Table 86. Thermo Fisher Scientific IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Thermo Fisher Scientific Recent Developments/Updates
Table 88. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 89. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 90. Merck KGaA Major Business
Table 91. Merck KGaA IVT mRNA Synthesis Service Product and Services
Table 92. Merck KGaA IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Merck KGaA Recent Developments/Updates
Table 94. Merck KGaA Competitive Strengths & Weaknesses
Table 95. AGC Basic Information, Manufacturing Base and Competitors
Table 96. AGC Major Business
Table 97. AGC IVT mRNA Synthesis Service Product and Services
Table 98. AGC IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Recent Developments/Updates
Table 100. AGC Competitive Strengths & Weaknesses
Table 101. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 102. Samsung Biologics Major Business
Table 103. Samsung Biologics IVT mRNA Synthesis Service Product and Services
Table 104. Samsung Biologics IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Samsung Biologics Recent Developments/Updates
Table 106. Samsung Biologics Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Manufacturing Base and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm IVT mRNA Synthesis Service Product and Services
Table 110. Recipharm IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. Curia Basic Information, Manufacturing Base and Competitors
Table 114. Curia Major Business
Table 115. Curia IVT mRNA Synthesis Service Product and Services
Table 116. Curia IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Curia Recent Developments/Updates
Table 118. Curia Competitive Strengths & Weaknesses
Table 119. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 120. VectorBuilder Major Business
Table 121. VectorBuilder IVT mRNA Synthesis Service Product and Services
Table 122. VectorBuilder IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. VectorBuilder Recent Developments/Updates
Table 124. VectorBuilder Competitive Strengths & Weaknesses
Table 125. Biomay Basic Information, Manufacturing Base and Competitors
Table 126. Biomay Major Business
Table 127. Biomay IVT mRNA Synthesis Service Product and Services
Table 128. Biomay IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biomay Recent Developments/Updates
Table 130. Biomay Competitive Strengths & Weaknesses
Table 131. Ricoh Basic Information, Manufacturing Base and Competitors
Table 132. Ricoh Major Business
Table 133. Ricoh IVT mRNA Synthesis Service Product and Services
Table 134. Ricoh IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Ricoh Recent Developments/Updates
Table 136. Ricoh Competitive Strengths & Weaknesses
Table 137. ARCALIS Basic Information, Manufacturing Base and Competitors
Table 138. ARCALIS Major Business
Table 139. ARCALIS IVT mRNA Synthesis Service Product and Services
Table 140. ARCALIS IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. ARCALIS Recent Developments/Updates
Table 142. ARCALIS Competitive Strengths & Weaknesses
Table 143. Bioneer Basic Information, Manufacturing Base and Competitors
Table 144. Bioneer Major Business
Table 145. Bioneer IVT mRNA Synthesis Service Product and Services
Table 146. Bioneer IVT mRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Bioneer Recent Developments/Updates
Table 148. Bioneer Competitive Strengths & Weaknesses
Table 149. Global Key Players of IVT mRNA Synthesis Service Upstream (Raw Materials)
Table 150. Global IVT mRNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. IVT mRNA Synthesis Service Picture
Figure 2. World IVT mRNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World IVT mRNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World IVT mRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World IVT mRNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. IVT mRNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World IVT mRNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of IVT mRNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for IVT mRNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for IVT mRNA Synthesis Service Markets in 2025
Figure 27. United States VS China: IVT mRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: IVT mRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World IVT mRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World IVT mRNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Research Grade
Figure 32. Preclinical Grade
Figure 33. GMP Grade
Figure 34. Other
Figure 35. World IVT mRNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World IVT mRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 37. World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale in 2025
Figure 38. Micro Scale (?1 mg)
Figure 39. Small Scale (>1?100 mg)
Figure 40. Pilot Scale (>100 mg?10 g)
Figure 41. Manufacturing Scale (>10 g)
Figure 42. World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale (2021-2032)
Figure 43. World IVT mRNA Synthesis Service Market Size by RNA Format, (USD Million), 2021 & 2025 & 2032
Figure 44. World IVT mRNA Synthesis Service Market Size Market Share by RNA Format in 2025
Figure 45. Conventional mRNA
Figure 46. Self-Amplifying RNA
Figure 47. World IVT mRNA Synthesis Service Market Size Market Share by RNA Format (2021-2032)
Figure 48. World IVT mRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World IVT mRNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. Academic and Research Institutes
Figure 52. Other
Figure 53. World IVT mRNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. IVT mRNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. IVT mRNA Synthesis Service Picture
Figure 2. World IVT mRNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World IVT mRNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World IVT mRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World IVT mRNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company IVT mRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. IVT mRNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World IVT mRNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India IVT mRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of IVT mRNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for IVT mRNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for IVT mRNA Synthesis Service Markets in 2025
Figure 27. United States VS China: IVT mRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: IVT mRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World IVT mRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World IVT mRNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Research Grade
Figure 32. Preclinical Grade
Figure 33. GMP Grade
Figure 34. Other
Figure 35. World IVT mRNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World IVT mRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 37. World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale in 2025
Figure 38. Micro Scale (?1 mg)
Figure 39. Small Scale (>1?100 mg)
Figure 40. Pilot Scale (>100 mg?10 g)
Figure 41. Manufacturing Scale (>10 g)
Figure 42. World IVT mRNA Synthesis Service Market Size Market Share by Batch Scale (2021-2032)
Figure 43. World IVT mRNA Synthesis Service Market Size by RNA Format, (USD Million), 2021 & 2025 & 2032
Figure 44. World IVT mRNA Synthesis Service Market Size Market Share by RNA Format in 2025
Figure 45. Conventional mRNA
Figure 46. Self-Amplifying RNA
Figure 47. World IVT mRNA Synthesis Service Market Size Market Share by RNA Format (2021-2032)
Figure 48. World IVT mRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World IVT mRNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. Academic and Research Institutes
Figure 52. Other
Figure 53. World IVT mRNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. IVT mRNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
